GSK369796 Dihydrochloride
GSK369796 Dihydrochlorideis an anti-malaria drug candidate. is an affordable and effective antimalarial and inhibits hERG potassium ion channel repolarization (IC50 of 7.5 μM) (In Vitro) :In vitro, GSK369796 Dihydrochloride can inhibit the growth of Plasmodium falciparum strains 3D7c, HB3c and K1d, with IC50s of 11.2±2.2, 12.6±5.3 and 13.2±3.2 nM, respectively. Protein binding is higher for GSK369796 Dihydrochloride (compound 4) compare to desethyl amodiaquine in the mouse (93 vs 74%) but similar in human (88 vs 86%) . GSK369796 Dihydrochloride can also inhibit hERG potassium ion channel repolarization with an IC50 of 7.5±0.8 μM. (In Vivo) :In vivo, GSK369796 Dihydrochloride can inhibit the growth of Plasmodium berghei ANKA with ED50 and ED90 of 2.8 and 4.7 mg/kg, respectively.
Product Specifications
CAS Number
1010411-21-8
Product Name Alternative
N-tert-butylisoquine
Purity
>98% (HPLC)
Solubility
DMSO:75 mg/mL (174.91 mM)
Smiles
Cl.Cl.CC (C) (C) NCc1ccc (Nc2ccnc3cc (Cl) ccc23) cc1O
Molecular Formula
C20H24Cl3N3O
Molecular Weight
428.78
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2-[ (tert-Butylamino) methyl]-5-[ (7-chloroquinolin-4-yl) amino]phenol Dihydrochloride
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog